Shudong Xia Selected Research

Myocardial Infarction

7/2019	Aberrant expression of TNRC6a and miR-21 during myocardial infarction.
2/2017	VEGF treatment promotes bone marrow-derived CXCR4+ mesenchymal stromal stem cell differentiation into vessel endothelial cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shudong Xia Research Topics

Disease

5	Hypertension (High Blood Pressure) 01/2023 - 01/2009
5	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2009
3	Atrial Fibrillation 04/2024 - 01/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2009
2	Stroke (Strokes) 01/2024 - 12/2006
2	Coronary Disease (Coronary Heart Disease) 01/2023 - 01/2021
2	Myocardial Infarction 07/2019 - 02/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2024
1	Hepatocellular Carcinoma (Hepatoma) 07/2023
1	Inflammation (Inflammations) 01/2022
1	Infarction (Infarctions) 07/2019
1	Vascular Diseases (Vascular Disease) 02/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015
1	Hyperlipidemias (Hyperlipidemia) 06/2015
1	Dyslipidemias (Dyslipidemia) 06/2015
1	Atrioventricular Block 05/2010
1	Tachycardia (Tachyarrhythmias) 05/2010
1	Cardiomyopathies (Cardiomyopathy) 01/2009
1	Heart Failure 01/2009
1	Hyperthyroidism 01/2009
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2009
1	Ventricular Tachycardia 04/2007
1	Ischemic Stroke 12/2006

Drug/Important Bio-Agent (IBA)

4	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2021
2	Testosterone (Sustanon)FDA Link 08/2015 - 01/2009
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2015 - 01/2009
1	Triglycerides (Triacylglycerol)IBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 04/2024
1	Anti-Arrhythmia AgentsIBA 01/2024
1	Fibrinogen (Factor I)FDA Link 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2023
1	Proteins (Proteins, Gene)FDA Link 07/2019
1	Messenger RNA (mRNA)IBA 07/2019
1	Purinergic P2X7 ReceptorsIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	CXC ChemokinesIBA 02/2017
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 06/2015
1	Coenzyme A (CoA)IBA 06/2015
1	Capsules (Microcapsules)IBA 06/2015
1	LipidsIBA 06/2015
1	Lipoproteins (Lipoprotein)IBA 06/2015
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2009
1	Angiotensin Receptor AntagonistsIBA 01/2009
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2009
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2009
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2006
1	Interleukin-1 (Interleukin 1)IBA 12/2006

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2010
3	Catheter Ablation 01/2021 - 04/2007
2	Radiofrequency Ablation 04/2024 - 04/2007
2	Stents 01/2023 - 04/2020
1	Precision Medicine 07/2023
1	Drug-Eluting Stents 01/2023
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022
1	Cell Transplantation 02/2017